Cancer of the Ovary
Showing 9976 - 10000 of >10,000
Cancer Trial in Saint Louis (Augmented Whole-body Scanning via Magnifying PET, FDG-PET/CT, 18F- fluorodeoxyglucose)
Not yet recruiting
- Cancer
- Augmented Whole-body Scanning via Magnifying PET
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Aug 18, 2022
Lung Cancer Trial in United States (Telehealth, In-person PC)
Recruiting
- Lung Cancer
- Telehealth
- In-person PC
-
Birmingham, Alabama
- +22 more
Mar 24, 2022
Non Muscular Invasive Bladder Cancer Trial in Worldwide (CG0070, n-dodecyl-B-D-maltoside)
Recruiting
- Non Muscular Invasive Bladder Cancer
- CG0070
- n-dodecyl-B-D-maltoside
-
Homewood, Alabama
- +58 more
Jun 16, 2022
Impact of Sarcopenia Using an Easy Psoas Area Measurement
Completed
- Sarcopenia
- Colectomy with anastomosis of any type
-
Pontoise, FranceCentre Hospitalier René Dubos
Jun 16, 2022
HER2 Low and Describe SoC, Treatment Patterns, and Outcome in
Completed
- Breast Cancer
- None (Observational study)
-
Pittsburgh, Pennsylvania
- +12 more
May 25, 2022
Pelvic Radiation Disease in Childhood Cancer Survivors
Not yet recruiting
- Radiation Disease
- (no location specified)
Sep 5, 2022
Transnasal Esophagoscopy (TNE) Esophageal Cancer Screening
Not yet recruiting
- Esophageal Cancer
- Transnasal Esophagoscopy (TNE)
-
Chicago, IllinoisMile Square Health Center-University of Illinois Hospital
Jul 27, 2022
Radiomics Based Multimodal Transvaginal Ultrasound Imaging in
Active, not recruiting
- Endometrial Cancer
- +2 more
- radiomics
-
Wuhan, Hubei, ChinaTongji Hospital of Tongji Medical College, Huazhong University o
May 18, 2022
Rectal Cancer, Comorbidities and Coexisting Conditions, Inoperable Disease Trial in Montreal (External beam radiotherapy +
Recruiting
- Rectal Cancer
- +3 more
- External beam radiotherapy + Endorectal brachytherapy
-
Montreal, Quebec, CanadaJewish General Hospital
Oct 25, 2022
Nasopharyngeal Carcinoma Trial in Singapore (Ipilimumab, Nivolumab)
Recruiting
- Nasopharyngeal Carcinoma
-
Singapore, SingaporeNational Cancer Center Singapore
Jul 20, 2022
Colo-rectal Cancer, Colon Polyp, Colonic Polyp Trial in Winnipeg (Access to colonoscopy web app)
Active, not recruiting
- Colo-rectal Cancer
- +6 more
- Access to colonoscopy web app
-
Winnipeg, Manitoba, Canada
- +1 more
Jun 7, 2022
Pancreatic Adenocarcinoma Trial in United States (Durvalumab, Stereotactic Ablative Body Radiotherapy (SABR))
Active, not recruiting
- Pancreatic Adenocarcinoma
- Durvalumab
- Stereotactic Ablative Body Radiotherapy (SABR)
-
Los Angeles, California
- +7 more
Aug 11, 2022
Head and Neck Tumors Trial in San Francisco (Registry)
Completed
- Head and Neck Neoplasms
- Registry
-
San Francisco, CaliforniaZuckerberg San Francisco General Hospital and Trauma Center
Jun 27, 2022
GastroEsophageal Cancer Trial in Tampa (Fitbit Data Collection, Nutrition Counseling, Survey)
Recruiting
- GastroEsophageal Cancer
- Fitbit Data Collection
- +2 more
-
Tampa, FloridaMoffitt Cancer Center
Jun 29, 2022
Pancreas Cancer, Metastatic Trial in Aalborg (Pembrolizumab, Irreversible electroporation)
Active, not recruiting
- Pancreas Cancer, Metastatic
- Pembrolizumab
- Irreversible electroporation
-
Aalborg, North Denmark Region, DenmarkDepartment of Oncology
Mar 8, 2022
Gastric Cancer Trial in Zhengzhou (Fruquintinib + RC48)
Not yet recruiting
- Gastric Cancer
- Fruquintinib + RC48
-
Zhengzhou, Henan, ChinaThe First Affiliated Hospital of Zhengzhou University
Feb 6, 2022
Survey Study: Financial Impact of Breast Cancer Treatment
Active, not recruiting
- Breast Cancer
- Quality of Life Surveys
-
Sayre, PennsylvaniaGuthrie Medical Group
Dec 14, 2021
Cancer, Cancer Pain Trial in Bhaktapur, Kathmandu (Clinical Pharmacist Intervention)
Recruiting
- Cancer
- Cancer Pain
- Clinical Pharmacist Intervention
-
Bhaktapur, Bagmati, Nepal
- +1 more
May 4, 2022
Solid Tumor Trial in United States (OBT076, a CD205-directed antibody-drug conjugate)
Recruiting
- Solid Tumor
- OBT076, a CD205-directed antibody-drug conjugate
-
Los Angeles, California
- +5 more
Jan 10, 2022
Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Portland (Ibrutinib, Obinutuzumab)
Completed
- Recurrent Mantle Cell Lymphoma
- Refractory Mantle Cell Lymphoma
- Ibrutinib
- Obinutuzumab
-
Portland, OregonOHSU Knight Cancer Institute
Dec 10, 2021
NSCLC (NSCLC) Trial in Canada, Japan, United States (iSABR, 25 Gray in 1 fraction for small peripheral tumors, iSABR, 50 Gray in
Completed
- Non-small Cell Lung Cancer (NSCLC)
- iSABR, 25 Gray in 1 fraction for small peripheral tumors
- +5 more
-
Stanford, California
- +3 more
Jul 27, 2022
Breast Cancer, Physical Activity Trial in Galveston, Houston (Active video game teleconference support group, Standard support
Active, not recruiting
- Breast Cancer
- Physical Activity
- Active video game teleconference support group
- Standard support group + pedometer
-
Galveston, Texas
- +1 more
Oct 26, 2021
Overall Survival of Stage I-III Appendiceal Adenocarcinoma
Completed
- Appendiceal Cancer
- Partial colecctomy
- Hemicolectomy
-
Weston, FloridaCleveland Clinic Flroida
Jul 6, 2022
Colon Cancer, Rectal Cancer, Liver Metastases Trial in San Francisco (Tas-102, SIR-Sphere)
Completed
- Colon Cancer
- +2 more
- Tas-102
- SIR-Sphere
-
San Francisco, CaliforniaUniversity of California San Francisco
Jul 28, 2022